Advertisement

Loading...

Grown Rogue International Inc.

GRIN.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.40
$-0.02(-4.76%)
Canadian Market opens in 16h 33m

Grown Rogue International Inc. (GRIN.CN) Stock Competitors & Peer Comparison

See (GRIN.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
GRIN.CNCA$0.41+5.13%104.8M10.50CA$0.04N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$7.72+9.90%2.8B12.97CA$0.58N/A
CURA.TOCA$2.94+11.36%2.3B-6.82-CA$0.44N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
GTII.CNCA$8.64+9.78%2.1B13.25CA$0.67N/A
CRON.TOCA$3.48+2.35%1.3B-117.33-CA$0.03N/A
TRUL.CNCA$7.75+9.93%1.3B-9.66-CA$0.80N/A
TLRY.TOCA$8.46+1.32%908.2M-0.27-CA$32.71N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

GRIN.CN vs CURA.CN Comparison April 2026

GRIN.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GRIN.CN stands at 104.8M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, GRIN.CN is priced at CA$0.41, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GRIN.CN currently has a P/E ratio of 10.50, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, GRIN.CN's ROE is +0.28%, compared to CURA.CN's ROE of -0.28%. Regarding short-term risk, GRIN.CN is more volatile compared to CURA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for GRIN.CN.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions